Although its molecular targets in ESCC remain undefined, evidence from ovarian cancer indicates that miR-718 directly targets VEGF, leading to the inhibition of tumor cell proliferation, invasion, and angiogenesis and increased apoptosis [115]. This evidence concerns the gene VEGFA and esophageal squamous cell carcinoma.